Fredrik Liedberg
51 – 60 of 223
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma : A population-based study
- Contribution to journal › Article
- 2022
-
Mark
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999 : a population-based study
- Contribution to journal › Article
-
Mark
Urostomal ileal conduit complications in association with abdominal wall mesh implantation
- Contribution to journal › Article
-
Mark
Adjuvant checkpoint inhibition after cystectomy–why, when, and for whom?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029 : A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
- Contribution to journal › Letter
-
Mark
International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma
- Contribution to journal › Scientific review
-
Mark
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications : a single center experience
- Contribution to journal › Article
-
Mark
Standardized care pathways for patients with suspected urinary bladder cancer : the Swedish experience
- Contribution to journal › Article
-
Mark
Cost Effectiveness of the Use of Prophylactic Mesh To Prevent Parastomal Hernia After Urinary Diversion with an Ileal Conduit
- Contribution to journal › Article
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
- Contribution to journal › Scientific review
